{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
NeurAxis, Inc.
Is NeurAxis, Inc. technically bullish or bearish?
As of June 2, 2025, the market trend has shifted to mildly bearish, driven by a bearish RSI and moving averages, despite a mildly bullish MACD, indicating overall bearish sentiment due to recent declines.
What does NeurAxis, Inc. do?
NeurAxis, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $2 million as of March 2025, with a market cap of $18.16 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -840.97%.
How big is NeurAxis, Inc.?
As of Jun 18, NeurAxis, Inc. has a market capitalization of 18.16 million, with net sales of 2.94 million and a net profit of -8.41 million over the last four quarters. Shareholder's funds are 2.07 million, and total assets are 4.76 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
